GO:0060368 regulation of Fc receptor mediated stimulatory signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060368 describes any process that modulates the rate, frequency, or extent of the Fc receptor mediated stimulatory signaling pathway, a key activation route in immune cells.
• Fc receptor stimulatory signaling is controlled by positive and negative regulators, including Sirt1, EphA4, WASP family proteins, and DAP12/KARAP adaptors [1,3,4,6,8].
• Dysregulation of this pathway contributes to autoimmune diseases, inflammatory disorders, and cancer, making it a target for therapeutic intervention [1,2,5,7].
• Key cell types affected include osteoclasts, mast cells, dendritic cells, natural killer cells, and B cells [1,3,4,5,8].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect regulatory nodes within this pathway.
• Understanding GO:0060368 aids in identifying new drug targets for diseases such as rheumatoid arthritis, allergy, and malignancies [1,4,6].
Description
The Fc receptor mediated stimulatory signaling pathway is a fundamental activation mechanism in the immune system, triggered when Fc receptors on the surface of immune cells bind to the Fc portion of antibodies. This pathway leads to cellular responses such as cytokine release, phagocytosis, and degranulation. The Gene Ontology term GO:0060368, regulation of Fc receptor mediated stimulatory signaling pathway, encompasses any process that modulates the rate, frequency, or extent of this signaling cascade. Understanding its regulation is critical because unchecked activation can drive autoimmune and inflammatory diseases, while insufficient signaling can impair host defense [1,5]. Researchers study this term to identify molecular brakes and accelerators that could be targeted therapeutically. For example, Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes, highlighting a potential target for allergic diseases. Similarly, EphA4 acts as a novel negative regulator of osteoclast activity, linking this pathway to bone homeostasis. The pathway is also modulated by co-stimulatory TNF receptors in cancer immunotherapy contexts. Thus, GO:0060368 represents a nexus of immune regulation with broad implications for health and disease.
regulation of Fc receptor mediated stimulatory signaling pathway At A Glance
| GO ID | GO:0060368 |
|---|---|
| GO term | regulation of Fc receptor mediated stimulatory signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of Fc receptor mediated stimulatory signalling pathway |
| Major function | Modulation of immune cell activation triggered by Fc receptor engagement |
| Key regulators | Sirt1, EphA4, WASP family proteins, DAP12/KARAP, ILT7-FcεRIγ [3,4,6,7,8] |
| Associated cell types | Osteoclasts, mast cells, dendritic cells, NK cells, B cells [1,3,4,5,8] |
| Disease relevance | Autoimmunity, inflammation, cancer, bone disorders [1,2,4,6] |
What Is GO:0060368?
GO:0060368, regulation of Fc receptor mediated stimulatory signaling pathway, is defined as any process that modulates the rate, frequency, or extent of the Fc receptor mediated stimulatory signaling pathway. In other words, it includes all molecular events that fine-tune the signals emanating from activating Fc receptors, ensuring appropriate immune cell responses.
Why Is regulation of Fc receptor mediated stimulatory signaling pathway Important in Cell Biology?
Regulation of Fc receptor mediated stimulatory signaling is crucial for maintaining immune homeostasis. Overactivation can lead to chronic inflammation, autoimmunity, and allergy, while inadequate regulation may result in immunodeficiency or impaired pathogen clearance. The pathway is also exploited in cancer immunotherapy, where co-stimulatory TNF receptors are harnessed to boost anti-tumor responses. Therefore, deciphering the regulatory mechanisms offers opportunities for therapeutic intervention in a wide range of diseases.
• Controls immune cell activation and effector functions, preventing excessive inflammation [1,5].
• Dysregulation is linked to autoimmune diseases such as rheumatoid arthritis and lupus [1,6].
• Modulates allergic responses through mast cell regulation.
• Influences osteoclast activity and bone remodeling [1,6].
• Plays a role in cancer immunosurveillance and immunotherapy.
• Affects dendritic cell function and cytokine production [5,7,8].
• Regulates B cell receptor signaling and mobility.
• Provides targets for drug development in inflammatory diseases [4,6].
• Helps understand host-pathogen interactions and vaccine responses.
• Offers insights into NK cell activation and cytotoxicity.
What Happens During regulation of Fc receptor mediated stimulatory signaling pathway?
Fc Receptor Engagement and Initial Phosphorylation
In simple terms: When antibodies bind to Fc receptors, they trigger a cascade of phosphorylation events inside the cell.
The stimulatory signaling pathway begins with the cross-linking of Fc receptors by immune complexes. This leads to phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) within associated signaling subunits, such as FcεRIγ or DAP12/KARAP [1,8]. Src family kinases mediate this phosphorylation, creating docking sites for SYK family kinases. This initial step is subject to regulation by phosphatases and kinases that modulate the threshold of activation.
Adaptor Protein Recruitment and Signalosome Assembly
In simple terms: Specialized adaptor proteins assemble into a signaling hub that amplifies the signal.
Upon ITAM phosphorylation, SYK and other kinases recruit adaptor proteins like LAT and SLP-76, forming a signalosome. DAP12/KARAP is a key adaptor in NK cells and dendritic cells, coupling to triggering receptors expressed on myeloid cells 2 (TREM2). This assembly is regulated by the availability of adaptors and their post-translational modifications. For instance, ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production in plasmacytoid dendritic cells, illustrating negative regulation at this stage.
Downstream Effector Activation
In simple terms: The signal travels to the nucleus and other organelles, turning on genes and cellular responses.
The signalosome activates downstream pathways including PLCγ, PI3K, and MAPK, leading to calcium flux, cytoskeletal rearrangement, and gene transcription. In mast cells, FcεRI-mediated activation is negatively regulated by Sirt1 through AMPK- and PTP1B-dependent processes, which dampen downstream signaling. In osteoclasts, EphA4 acts as a negative regulator by interfering with downstream signaling events. These examples highlight the multilayered regulation of effector activation.
Cytoskeletal Reorganization and Cell Mobility
In simple terms: The cell changes its shape and moves, which is important for immune cell function.
Activation of Fc receptors induces actin cytoskeleton remodeling, essential for phagocytosis, degranulation, and cell migration. WASP family proteins regulate the mobility of the B cell receptor during signaling activation, demonstrating a direct link between cytoskeletal dynamics and Fc receptor signaling. This regulation ensures that immune cells can efficiently engage targets and form immune synapses.
Termination and Negative Feedback
In simple terms: The signal is turned off to prevent excessive immune responses.
Negative feedback loops involving phosphatases (e.g., SHIP, SHP-1) and ubiquitin ligases terminate the signal. Sirt1 negatively regulates FcεRI-mediated mast cell activation, partly by promoting PTP1B activity. EphA4 also serves as a negative regulator in osteoclasts. These mechanisms are critical for preventing chronic inflammation and autoimmunity.
Key Genes Involved in GO:0060368 regulation of Fc receptor mediated stimulatory signaling pathway
The following genes and proteins are key players in the regulation of Fc receptor mediated stimulatory signaling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Sirt1 | Negative regulator of FcεRI-mediated mast cell activation via AMPK and PTP1B | Target for allergic and inflammatory diseases |
| EphA4 | Negative regulator of osteoclast activity | Potential therapeutic target for bone loss |
| WASP family proteins | Regulate B cell receptor mobility during signaling | Implications for immunodeficiency and autoimmunity |
| DAP12/KARAP | Adaptor in NK and dendritic cell stimulatory signaling | Cancer immunotherapy and innate immune regulation |
| ILT7-FcεRIγ | Inhibits TLR-induced interferon production in pDCs | Autoimmune and antiviral responses |
| FcγRI (CD64) | High-affinity IgG receptor on dendritic cells | Antigen presentation and vaccine design |
| TREM2 | Triggering receptor on myeloid cells coupled to DAP12 | Neurodegeneration and cancer |
| SYK | Kinase downstream of ITAM phosphorylation | Broad role in immune signaling |
| PLCγ | Mediates calcium flux and PKC activation | Mast cell and osteoclast activation |
| PI3K | Generates PIP3 for signalosome assembly | Cell survival and proliferation |
| MAPK | Transmits signals to nucleus for gene expression | Inflammation and cytokine production |
| SHIP | Phosphatase that terminates signaling | Negative regulation of immune activation |
| SHP-1 | Phosphatase that dampens Fc receptor signaling | Autoimmunity and cancer |
| LAT | Adaptor protein in signalosome | T cell and mast cell signaling |
| SLP-76 | Adaptor protein in signalosome | Hematopoietic signaling |
| PTP1B | Phosphatase involved in Sirt1-mediated negative regulation | Metabolic and inflammatory diseases |
| AMPK | Energy sensor mediating Sirt1 effects | Metabolic regulation of immune cells |
How Is regulation of Fc receptor mediated stimulatory signaling pathway Regulated?
The regulation of Fc receptor mediated stimulatory signaling is achieved through a balance of positive and negative regulators. Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes. EphA4 acts as a novel negative regulator of osteoclast activity. WASP family proteins regulate B cell receptor mobility, influencing signaling duration. Additionally, ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production, providing a negative feedback mechanism. These regulatory mechanisms ensure appropriate immune responses and prevent pathology.
regulation of Fc receptor mediated stimulatory signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Sirt1 | Allergic inflammation, mast cell activation | Knockout or overexpression in mast cells |
| EphA4 | Rheumatoid arthritis, bone erosion | Knockout mice or osteoclast-specific deletion |
| DAP12/KARAP | Cancer immunotherapy, NK cell function | Knock-in of human DAP12 in mice |
| FcγRI (CD64) | Antigen presentation, vaccine response | Human dendritic cell models |
| ILT7-FcεRIγ | Autoimmune interferonopathies | Plasmacytoid dendritic cell lines |
Autoimmune and Inflammatory Diseases
Dysregulation of Fc receptor signaling is implicated in autoimmune diseases such as rheumatoid arthritis and lupus. Overactivation of osteoclasts, driven by Fc receptor signaling, leads to bone erosion in rheumatoid arthritis [1,6]. Negative regulators like EphA4 are potential therapeutic targets to dampen osteoclast activity. In mast cells, loss of Sirt1-mediated negative regulation can exacerbate allergic inflammation. Thus, restoring regulatory balance is a therapeutic strategy.
Cancer and Immunotherapy
Fc receptor signaling in dendritic cells and NK cells is critical for anti-tumor immunity. Co-stimulatory TNF receptors are harnessed in cancer immunotherapy to boost Fc receptor-mediated activation. DAP12/KARAP adaptor is involved in NK cell stimulatory capacity, which can be exploited for cancer treatment. Conversely, excessive regulatory signals may impair tumor surveillance.
Allergy and Mast Cell Disorders
FcεRI-mediated mast cell activation is central to allergic reactions. Sirt1 negatively regulates this pathway, and its modulation could reduce allergic symptoms. Understanding the regulatory mechanisms may lead to new anti-allergy therapies.
Bone Disorders
Osteoclasts are regulated by Fc receptor signaling, and EphA4 negatively regulates osteoclast activity. Imbalances can lead to osteoporosis or osteopetrosis. Targeting regulatory nodes may help treat bone diseases.
From regulation of Fc receptor mediated stimulatory signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Sirt1 regulate FcεRI signaling in mast cells? | Sirt1 knockout and overexpression mast cell lines |
| What is the role of EphA4 in osteoclast regulation? | EphA4 knockout mice and osteoclast cultures |
| How does WASP regulate B cell receptor mobility? | WASP knockout B cell lines and imaging |
| Does DAP12/KARAP enhance NK cell stimulatory capacity? | DAP12 knock-in or knockout NK cells |
| What is the effect of ILT7-FcεRIγ on TLR signaling? | ILT7 overexpression in pDC lines |
| Can FcγRI be targeted for vaccine enhancement? | FcγRI knock-in dendritic cells |
How to Study the regulation of Fc receptor mediated stimulatory signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Loss-of-function effects on signaling | Identify novel regulators [4,6] |
| Phosphoproteomics | Phosphorylation changes | Map signaling cascade [1,8] |
| Live-cell imaging | Receptor mobility and cytoskeleton | Study WASP function |
| RNA-seq | Gene expression changes | Transcriptional output |
| Flow cytometry | Surface marker expression and activation | Immune cell phenotyping [5,7] |
| ELISA | Cytokine production | Measure inflammatory mediators [7,8] |
| Western blot | Protein phosphorylation and expression | Validate signaling events [4,6] |
CRISPR-Cas9 Knockout Screens
Genome-wide CRISPR knockout screens can identify novel regulators of Fc receptor signaling. For example, knocking out candidate genes like Sirt1 or EphA4 in immune cell lines followed by Fc receptor stimulation and readout of activation markers can reveal their roles [4,6].
Phosphoproteomics
Mass spectrometry-based phosphoproteomics can map the signaling cascade downstream of Fc receptor engagement, identifying phosphorylation events on adaptors and kinases. This approach helps quantify changes in signaling when regulatory genes are perturbed [1,8].
Live-Cell Imaging
Fluorescence microscopy can visualize the mobility of receptors and cytoskeletal dynamics during signaling. WASP family proteins were shown to regulate B cell receptor mobility using live-cell imaging.
RNA Sequencing
Transcriptomic profiling after Fc receptor stimulation can reveal gene expression changes mediated by regulatory pathways. This is useful for understanding how negative regulators like Sirt1 alter the transcriptional landscape.
How CRISPR Can Be Used to Study GO:0060368 regulation of Fc receptor mediated stimulatory signaling pathway
Knockout
CRISPR knockout of regulatory genes such as Sirt1 or EphA4 in immune cell lines or primary cells can reveal their role in Fc receptor signaling. For instance, Sirt1 knockout in mast cells would test its negative regulatory function. EphA4 knockout in osteoclasts can confirm its role as a negative regulator.
Point Mutation
Introducing point mutations in key phosphorylation sites of adaptors like DAP12 or ITAM tyrosines can dissect their contribution to signaling. This approach helps understand how specific residues regulate pathway activation [1,8].
Knock-in
Knock-in of human Fc receptors or adaptors into mouse models can humanize the system for drug testing. For example, knocking in human DAP12 into mice allows study of human-specific regulatory mechanisms.
Overexpression
Overexpression of negative regulators like ILT7-FcεRIγ or Sirt1 can suppress Fc receptor signaling, providing a gain-of-function model to study pathway inhibition [4,7].
How EDITGENE Supports regulation of Fc receptor mediated stimulatory signaling pathway Research
Researchers studying regulation of Fc receptor mediated stimulatory signaling pathway-related genes often need to determine whether a candidate gene is causally involved in modulating immune cell activation. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for regulation of Fc receptor mediated stimulatory signaling pathway research.
Frequently Asked Questions About regulation of Fc receptor mediated stimulatory signaling pathway
What is GO:0060368?
GO:0060368 is a Gene Ontology term for regulation of Fc receptor mediated stimulatory signaling pathway, describing any process that modulates the rate, frequency, or extent of Fc receptor stimulatory signaling.
What genes are involved in regulation of Fc receptor mediated stimulatory signaling pathway?
Key genes include Sirt1, EphA4, WASP family proteins, DAP12/KARAP, ILT7-FcεRIγ, and FcγRI [3,4,5,6,7,8].
How does Sirt1 regulate Fc receptor signaling?
Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes.
What is the role of EphA4 in Fc receptor signaling?
EphA4 acts as a novel negative regulator of osteoclast activity, dampening Fc receptor-mediated signaling.
Which diseases are associated with dysregulation of Fc receptor signaling?
Dysregulation is linked to autoimmune diseases, allergic inflammation, cancer, and bone disorders [1,2,4,6].
How can CRISPR be used to study this pathway?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of regulatory genes in immune cells [4,6,8].
What cell types are most relevant to study GO:0060368?
Osteoclasts, mast cells, dendritic cells, NK cells, and B cells are key cell types [1,3,4,5,8].
What methods are used to study regulation of Fc receptor signaling?
CRISPR screens, phosphoproteomics, live-cell imaging, RNA-seq, flow cytometry, and ELISA are commonly used [1,3,4,7,8].
Can Fc receptor signaling be targeted for cancer therapy?
Yes, co-stimulatory TNF receptors and DAP12/KARAP are being harnessed for cancer immunotherapy [2,8].
What is the role of DAP12/KARAP in this pathway?
DAP12/KARAP is an adaptor that couples triggering receptors to stimulatory signaling in NK and dendritic cells.
Conclusion
GO:0060368, regulation of Fc receptor mediated stimulatory signaling pathway, is a critical process in immune regulation with far-reaching implications for health and disease. Key regulators such as Sirt1, EphA4, and WASP family proteins fine-tune signaling to prevent autoimmunity and inflammation while enabling effective immune responses. Understanding these mechanisms offers therapeutic opportunities in autoimmune diseases, allergy, cancer, and bone disorders. CRISPR-based models and advanced omics technologies are indispensable for dissecting this pathway. EDITGENE provides the tools and expertise to accelerate discoveries in this field.
References
- 1. Humphrey MB et al.. 2016. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.. Clin Rev Allergy Immunol 51(1):48-58 PMID: 26573914
- 2. Waight JD et al.. 2017. Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.. Hum Antibodies 25(3-4):87-109 PMID: 28085016
- 3. Rey-Suarez I et al.. 2020. WASP family proteins regulate the mobility of the B cell receptor during signaling activation.. Nat Commun 11(1):439 PMID: 31974357
- 4. Li X et al.. 2017. Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes.. Sci Rep 7(1):6444 PMID: 28744004
- 5. Fanger NA et al.. 1997. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells.. J Immunol 158(7):3090-8 PMID: 9120261
- 6. Stiffel V et al.. 2014. EphA4 receptor is a novel negative regulator of osteoclast activity.. J Bone Miner Res 29(4):804-19 PMID: 23983218
- 7. Cao W et al.. 2006. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production.. J Exp Med 203(6):1399-405 PMID: 16735691
- 8. Terme M et al.. 2004. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.. J Immunol 172(10):5957-66 PMID: 15128777
